Jump to content



Photo

Sorrento Therapeutics Skyrocketing Today The company might have found a way to end the ongoing coronavirus pandemic.


  • Please log in to reply
6 replies to this topic

#1 .Blizzard

.Blizzard

    Member

  • Traders-Talk User
  • 1,128 posts

Posted 15 May 2020 - 05:34 PM

So what
In an interview with Fox News, Dr. Henry Ji, CEO of Sorrento Therapeutics, said:

We want to emphasize there is a cure. There is a solution that works 100 percent. If we have the neutralizing antibody in your body, you don't need the social distancing. You can open up a society without fear.

The cure in question is an antibody called STI-1499 that Sorrento Therapeutics has been developing. If Dr. Ji's claims prove accurate, it would be, to put it mildly, a big deal.


Medical professionals believe that a relatively large percentage of those who contract the SARS-CoV-2 virus that causes COVID-19 are asymptomatic, and these silent carriers of the virus can still infect others. This factor explains why many are still fearful that there will be a second wave of COVID-19 infections, especially since several states are now beginning to ease social-distancing rules. These fears will never truly subside without a reliable way to prevent new COVID-19 infections.

Now what
Sorrento Therapeutics could reap immense financial benefits if it has indeed found a way to treat and prevent COVID-19. However, investors should remember that until the biotech company demonstrates the efficacy of its product, nothing is set in stone.

Something big just happened

I don't know about you, but I always pay attention when one of the best growth investors in the world gives me a stock tip. Motley Fool co-founder David Gardner and his brother, Motley Fool CEO Tom Gardner, just revealed two brand new stock recommendations. Together, they've tripled the stock market's return over the last 17 years.* And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their ideas.





https://www-fool-com...ting-today.aspx

Edited by .Blizzard, 15 May 2020 - 05:37 PM.

 
 
 


#2 gannman

gannman

    Member

  • Traders-Talk User
  • 5,364 posts

Posted 15 May 2020 - 06:42 PM

lets hope that would be amazing


feeling mellow with the yellow metal


#3 slupert

slupert

    Member

  • Traders-Talk User
  • 1,430 posts

Posted 16 May 2020 - 01:01 PM

What perfect timing, https://investors.so...64-c156633ab829



#4 slupert

slupert

    Member

  • Traders-Talk User
  • 1,430 posts

Posted 16 May 2020 - 01:03 PM

https://investors.so...64-c156633ab829



#5 CLK

CLK

    Member

  • Traders-Talk User
  • 10,485 posts

Posted 16 May 2020 - 01:51 PM

 

 

 

I don't buy penny stocks, very few make it.



#6 slupert

slupert

    Member

  • Traders-Talk User
  • 1,430 posts

Posted 16 May 2020 - 02:55 PM

On September 21, 2009, QuikByte Software, Inc., a Colorado corporation and shell company, or QuikByte, consummated its acquisition of Sorrento Therapeutics, Inc., a Delaware corporation and private concern, or STI, in a reverse merger, or the Merger. Pursuant to the Merger, all of the issued and outstanding shares of STI common stock were converted into an aggregate of 6,775,032 shares of QuikByte common stock and STI became a wholly owned subsidiary of QuikByte. The holders of QuikByte’s common stock immediately prior to the Merger held an aggregate of 2,228,333 shares of QuikByte’s common stock immediately following the Merger. We were originally incorporated as San Diego Antibody Company in California in 2006 and were renamed “Sorrento Therapeutics, Inc.” and reincorporated in Delaware in 2009, prior to the Merger. QuikByte was originally incorporated in Colorado in 1989. Following the Merger, on December 4, 2009, QuikByte reincorporated under the laws of the State of Delaware, or the Reincorporation. Immediately following the Reincorporation, on December 4, 2009, we merged with and into QuikByte, the separate corporate existence of STI ceased and QuikByte continued as the surviving corporation, or the Roll-Up Merger. Pursuant to the certificate of merger filed in connection with the Roll-Up Merger, QuikByte’s name was changed from “QuikByte Software, Inc.” to “Sorrento Therapeutics, Inc.” Our principal executive offices are located at 4955 Directors Place, San Diego, CA 92121, and our telephone number at that address is (858) 203- 4100. Our website is www.sorrentotherapeutics.com. Any information contained on, or that can be accessed through, our website is not incorporated by reference into, nor is it in any way part of this prospectus and should not be relied upon in connection with making any decision with respect to an investment in our securities. We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC. You may obtain any of the documents filed by us with the SEC at no cost from the SEC’s website at http://www.sec.gov. S-4



#7 dowdeva

dowdeva

    Member

  • Traders-Talk User
  • 510 posts

Posted 17 May 2020 - 03:23 PM

There is no pandemic